Penumbra (PEN) Income from Non-Controlling Interests (2018 - 2021)
Penumbra (PEN) posted quarterly Income from Non-Controlling Interests of -$819000.0 for Q3 2021, up 22.81% year-over-year from -$666891.0 in Q3 2020, and up 12.12% quarter-over-quarter from -$932000.0 in Q2 2021.
Penumbra (PEN) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
Penumbra (PEN) has reported Income from Non-Controlling Interests for 4 consecutive years, with -$819000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Income from Non-Controlling Interests rose 22.81% year-over-year to -$819000.0; the TTM figure through Jun 2022 stood at -$819000.0 (up 79.1% YoY), while the FY2021 annual figure was -$2.7 million, up 25.15% from the prior year.
- Income from Non-Controlling Interests advanced to -$819000.0 in Q3 2021 per PEN's latest filing, from -$932000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$195000.0 in Q4 2018 and bottomed at -$3.5 million in Q3 2018.
- Historically, Income from Non-Controlling Interests has averaged -$873923.1 across 4 years, with a median of -$819000.0 in 2021.
- Annual changes were most pronounced in 2019 — Income from Non-Controlling Interests jumped 86.18% — and 2020, when it slumped 177.58%.
- Penumbra's Income from Non-Controlling Interests stood at -$195000.0 in 2018, then sank by 98.97% to -$388000.0 in 2019, then plunged by 161.86% to -$1.0 million in 2020, then rose by 19.39% to -$819000.0 in 2021.
- Business Quant data shows PEN's Income from Non-Controlling Interests at -$819000.0 in Q3 2021, -$932000.0 in Q2 2021, and -$910000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 900,000.00 |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -819,000.00 |
| Jun 30, 2021 | -932,000.00 |
| Mar 31, 2021 | -910,000.00 |
| Dec 31, 2020 | -1.02 Mn |
| Sep 30, 2020 | -1.06 Mn |
| Jun 30, 2020 | -941,000.00 |
| Mar 31, 2020 | -537,000.00 |
| Dec 31, 2019 | -388,000.00 |
| Sep 30, 2019 | -483,000.00 |
| Jun 30, 2019 | -339,000.00 |
| Mar 31, 2019 | -244,000.00 |
| Dec 31, 2018 | -195,000.00 |
| Sep 30, 2018 | -3.50 Mn |